Fluorescent silver(i) and gold(i)–N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights

Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs

(2012) Wukun Liu et al.   CHEMICAL SOCIETY REVIEWS

Ruthenium(II)-Arene Complexes with Strong Fluorescence: Insight into the Underlying Mechanism

(2012) Qianxiong Zhou et al.   CHEMISTRY-A EUROPEAN JOURNAL

Anticancer Activity of Silver-N-Heterocyclic Carbene Complexes: Caspase-Independent Induction of Apoptosis via Mitochondrial Apoptosis-Inducing Factor (AIF)

(2012) Laure Eloy et al.   ChemMedChem

Next-Generation Anticancer Metallodrugs

(2012) Seiji Komeda et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

BODIPY–phosphane as a versatile tool for easy access to new metal-based theranostics

(2012) Semra Tasan et al.   DALTON TRANSACTIONS

Synthesis and Biological Activity of Ester- and Amide-Functionalized Imidazolium Salts and Related Water-Soluble Coinage Metal N-Heterocyclic Carbene Complexes

(2012) Maura Pellei et al.   INORGANIC CHEMISTRY

Gold(I) Carbene Complexes Causing Thioredoxin 1 and Thioredoxin 2 Oxidation as Potential Anticancer Agents

(2012) Esther Schuh et al.   JOURNAL OF MEDICINAL CHEMISTRY

Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds

(2011) Angela Casini et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

In Vitro and in Vivo Fluorescent Imaging of a Monofunctional Chelated Platinum Complex Excitable Using Visible Light

(2011) Shengde Wu et al.   INORGANIC CHEMISTRY

Exploring the mechanisms of metal­based pharmacological agents via an integrated approach

(2011) Angela Casini   JOURNAL OF INORGANIC BIOCHEMISTRY

Comparative in Vitro Evaluation of N-Heterocyclic Carbene Gold(I) Complexes of the Benzimidazolylidene Type

(2011) Riccardo Rubbiani et al.   JOURNAL OF MEDICINAL CHEMISTRY

Metal-Based Inhibition of Poly(ADP-ribose) Polymerase − The Guardian Angel of DNA

(2011) Filipa Mendes et al.   JOURNAL OF MEDICINAL CHEMISTRY

Visualising gold inside tumour cells following treatment with an antitumour gold(i) complex

(2011) Louise E. Wedlock et al.   Metallomics

Gold compounds as therapeutic agents for human diseases

(2011) Susan J. Berners-Price et al.   Metallomics

Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin

(2010) Kristin K. Brown et al.   FEBS LETTERS

Noble metal targeting of thioredoxin reductase — covalent complexes with thioredoxin and thioredoxin-related protein of 14kDa triggered by cisplatin

(2010) Stefanie Prast-Nielsen et al.   FREE RADICAL BIOLOGY AND MEDICINE

In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands

(2010) Carlo Santini et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Organometallic Anticancer Compounds

(2010) Gilles Gasser et al.   JOURNAL OF MEDICINAL CHEMISTRY

The Medicinal Applications of Imidazolium Carbene−Metal Complexes

(2009) Khadijah M. Hindi et al.   CHEMICAL REVIEWS

Coinage Metal−N-Heterocyclic Carbene Complexes

(2009) Joseph C. Y. Lin et al.   CHEMICAL REVIEWS

Anticancer Therapeutics That Target Selenoenzymes: Synthesis, Characterization, in vitro Cytotoxicity, and Thioredoxin Reductase Inhibition of a Series of Gold(I) Complexes Containing Hydrophilic Phosphine Ligands

(2009) Elena Vergara et al.   ChemMedChem

On the medicinal chemistry of gold complexes as anticancer drugs

(2009) Ingo Ott   COORDINATION CHEMISTRY REVIEWS

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

(2009) Alberto Bindoli et al.   COORDINATION CHEMISTRY REVIEWS

Synthesis and biological studies of some gold(I) complexes containing functionalised alkynes

(2009) Esther Schuh et al.   DALTON TRANSACTIONS

Metal-NHC complexes: a survey of anti-cancer properties

(2009) Marie-Laure Teyssot et al.   DALTON TRANSACTIONS

Naphthalimide gold(i) phosphine complexes as anticancer metallodrugs

(2009) Christoph P. Bagowski et al.   DALTON TRANSACTIONS

Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift

(2009) Maria Pia Rigobello et al.   FREE RADICAL BIOLOGY AND MEDICINE

OLEX2: a complete structure solution, refinement and analysis program

(2009) Oleg V. Dolomanov et al.   JOURNAL OF APPLIED CRYSTALLOGRAPHY

A Gold(I) Phosphine Complex Containing a Naphthalimide Ligand Functions as a TrxR Inhibiting Antiproliferative Agent and Angiogenesis Inhibitor

(2009) Ingo Ott et al.   JOURNAL OF MEDICINAL CHEMISTRY

The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation

(2008) Andrew G. Cox et al.   BIOCHEMICAL PHARMACOLOGY

Combined arene ruthenium porphyrins as chemotherapeutics and photosensitizers for cancer therapy

(2008) Frédéric Schmitt et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY